BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Biopharma Companies Entering 2021 With New Collabs, Partnerships

  Here’s a run-down of some of the most recent collaboration announcements this week.

  January 8, 2021

   · 

  4 min read

   · 

  Brandon May
• 

  Drug Development

  COVID-19 News: Vaccine Protection Likely to Last for Years, Be Effective Against Variants

  News, much of it good, keeps coming in about the efficacy of the various COVID-19 vaccines. Here’s a look.

  January 8, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Clinical Catch-Up: January 4-8

  The new year began with a fairly low level of clinical trial news. Here’s a look.

  January 8, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Money Matters: More than $350 Million Raised to Advance Novel Therapeutics

  BioSpace provides a brief look at the funds raised and what the finances will be used to address.

  January 8, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Chinook Applies Precision Medicine to Kidney Therapeutics for Rapid Advances

  When Chinook Therapeutics looks at 2021, it foresees a host of clinical trials that will bring precision medicine to the kidney disease space.

  January 8, 2021

   · 

  3 min read

   · 

  Gail Dutton
• 

  Business

  Two Companies Launch with Diverse Approaches for Improving Cancer Treatments

  Mana Therapeutics takes aim at solid tumors with allogenic cell therapies and Aulos Bioscience sees a new path for IL-2 monoclonal antibodies.

  January 8, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Sanofi Executives Predict 2021 Will be ‘Transformative’ Year for Company

  Frank Nestle, Sanofi’s chief scientific officer and Global Head of Research, and Dietmar Berger, Sanofi’s chief medical officer and Global Head of Development, provided an overview of the company’s clinical activities and highlighted some assets that will be key revenue drives for the company.

  January 8, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Deals

  Starting the Year Dropping Cash - Two Companies Scooped Up This Week

  Merck KGaA buys Amptec for mRNA tech and Chimerix acquires Oncoceutics for cancer pipeline.

  January 8, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Business

  Biopharma CEOs on What to Expect at 2021 J.P. Morgan Healthcare Conference

  BioSpace spoke to executives from four companies about their expectations for the conference and the coming year.

  January 8, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Genetown

  Sarepta Stock Plunges 51.9% on Mixed Muscular Dystrophy Results

  Sarepta Therapeutics announced topline results from Part 1 of Study SRP-9001-102 for its gene therapy SRP-9001 for Duchenne muscular dystrophy.

  January 8, 2021

   · 

  3 min read

   · 

  Mark Terry